Black Diamond Therapeutics, Inc.

NASDAQ:BDTX

2.99 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -82.442-91.169-125.596-67.254-35.258-8.931-4.602
Depreciation & Amortization 0.4370.5080.2050.0520.0470.0440.024
Deferred Income Tax -0.59702.1791.725000.412
Stock Based Compensation 9.60412.19714.0377.7653.6430.0640.005
Change In Working Capital 3.686-9.9017.025.0420.4630.3541.744
Accounts Receivables 0000000
Inventory 0000000
Accounts Payables 0.597-2.231.5691.0691.4540.264-0.059
Other Working Capital 3.089-7.6715.4513.973-0.9910.091.803
Other Non Cash Items 2.5953.2832.0070.5246.4310.0150.066
Operating Cash Flow -66.717-85.082-100.148-52.146-24.674-8.454-2.351
Investing Activities:
Investments In Property Plant And Equipment -0.033-0.192-2.71-0.142-0.021-0.076-0.077
Acquisitions Net 0.0950.0092.70.118000
Purchases Of Investments -61.887-60.141-49.508-372.477000
Sales Maturities Of Investments 78.171113.69182.83190.928000
Other Investing Activites 0.0160.054-2.7-0.118-0.02100
Investing Cash Flow 16.34653.366130.613-281.691-0.021-0.076-0.077
Financing Activities:
Debt Repayment 000000-0.05
Common Stock Issued 71.9320.1770.729214.944129.49952.3120.1
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities 0.08200.001214.944-1.74352.3129.924
Financing Cash Flow 71.9320.1770.729214.944127.75652.3129.974
Other Information:
Effect Of Forex Changes On Cash 0.345000000
Net Change In Cash 21.906-31.53931.194-118.893103.06143.7827.546
Cash At End Of Period 56.22135.48367.02235.828154.72151.667.878